Pogson Zara E K, Antoniak Marilyn D, Pacey Sarah J, Lewis Sarah A, Britton John R, Fogarty Andrew W
Division of Epidemiology and Public Health, University of Nottingham, Clinical Sciences Building, Nottingham City Hospital, Nottingham, NG5 1PB, UK.
Am J Respir Crit Care Med. 2008 Jul 15;178(2):132-8. doi: 10.1164/rccm.200802-287OC. Epub 2008 May 1.
Observational studies and initial randomized trials have indicated that a low sodium diet may improve asthma control.
We tested the hypothesis that a low sodium diet would improve asthma control over a 6-week period.
Participants with a physician diagnosis of asthma and measurable bronchial reactivity to methacholine entered a randomized double-blind placebo-controlled trial. All adopted a low sodium diet and were randomized to receive either 80 mmol/day of oral sodium supplements (normal sodium intake) or matched placebo (low sodium intake) for 6 weeks. The primary outcome was change in bronchial reactivity to methacholine; secondary outcomes were change in lung function, morning and evening peak expiratory flow, asthma symptoms score, daily bronchodilator use, Juniper Standardized Asthma Quality of Life Questionnaire score, and atopy.
A total of 220 individuals entered the study, of whom 199 completed the protocol. In the low sodium-intake group, mean daily urinary sodium excretion decreased by 20 mmol (SD, 64 mmol) and in the normal-sodium-intake group increased by 28 mmol (SD, 74 mmol). There were no differences between the two groups in the primary or secondary outcome measures; the mean difference in bronchial reactivity between the low- and normal-intake groups was -0.03 doubling doses of methacholine (95% confidence interval, -0.60 to 0.53).
The use of a low sodium diet as an adjunctive therapy to normal treatment has no additional therapeutic benefit in adults with asthma and bronchial reactivity to methacholine.
观察性研究和初步随机试验表明,低钠饮食可能改善哮喘控制。
我们检验了低钠饮食在6周内可改善哮喘控制的假设。
经医生诊断为哮喘且对乙酰甲胆碱有可测量支气管反应性的参与者进入一项随机双盲安慰剂对照试验。所有参与者均采用低钠饮食,并被随机分为接受80 mmol/天的口服钠补充剂(正常钠摄入量)或匹配的安慰剂(低钠摄入量),为期6周。主要结局是对乙酰甲胆碱的支气管反应性变化;次要结局包括肺功能变化、早晚呼气峰值流速、哮喘症状评分、每日支气管扩张剂使用情况、朱尼珀标准化哮喘生活质量问卷评分和特应性。
共有220人进入研究,其中199人完成了方案。在低钠摄入组,平均每日尿钠排泄量减少了20 mmol(标准差,64 mmol),而正常钠摄入组增加了28 mmol(标准差,74 mmol)。两组在主要或次要结局指标上无差异;低钠摄入组与正常摄入组之间支气管反应性的平均差异为-0.03倍乙酰甲胆碱剂量(95%置信区间,-0.60至0.53)。
对于患有哮喘且对乙酰甲胆碱有支气管反应性的成年人,使用低钠饮食作为常规治疗的辅助疗法并无额外治疗益处。